What we do

Endocrine – Metabolic Expertise and Experience

The incidence of diabetes and other endocrinological conditions is rapidly increasing on a global scale. 

Endo – Metabolic CRO Expert

There are over 70 million patients diagnosed with Diabetes Type I and II in the countries covered by us.

As health budgets are limited in certain areas, patients have limited access to modern treatments such as insulins, DPP-4 inhibitors and GLP1 agonists, so they are eager to participate in clinical trials.

75 Studies conducted

53% of Phase II and Phase III
Endocrine - Metabolic trials by phase

3 450+

patients enrolled


Close collaboration with

300+ sites

14 indications in the last 5 years

Optimapharm’s top 5 indications in Endocrine – Metabolic studies
Endocrine Metabolic CRO

Staff experience

138 staff members with Endocrine – Metabolic projects experience
Endocrine-Metabolic staff experience


Case study


Video – DM2 experience